Finance

Lists
Q3 2026 earnings
See details
PRN:TSE
Profound Medical Corp
CA$9.64
-2.63%
(-0.26) 1D
Nov 5, 4:00:00 PM GMT-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for PRN...
Open
CA$9.84
High
CA$10.00
Low
CA$9.39
Mkt. cap
352.46M
Avg. vol.
15.28K
Volume
9.30K
52-wk high
CA$12.40
52-wk low
CA$6.52
EPS
-CA$1.38
Beta
0.63
Shares outstanding
36.53M
No. of employees
162
Open
CA$9.84
High
CA$10.00
Low
CA$9.39
Mkt. cap
352.46M
Avg. vol.
15.28K
Volume
9.30K
52-wk high
CA$12.40
52-wk low
CA$6.52
EPS
-CA$1.38
Beta
0.63
Shares outstanding
36.53M
No. of employees
162
News stories
From web sources and news partners
About Profound Medical Corp
CEO-
Employees162
Founded-
HeadquartersMississauga, Ontario, Canada
SectorHealth Care
IndustryMedical device
Websiteprofoundmedical.com
Awaiting results...
Call Time: Thu, Nov 5, 4:30 PM
Fiscal period
Q3 2026
- / -CA$0.27
Revenue / Est. (CAD)
- / 13.81M
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.29M
5.98M
5.34M
2.48M
Cost of goods sold
1.36M
1.99M
1.50M
536.00K
Cost of revenue
1.36M
1.99M
1.50M
536.00K
Research and development expenses
5.42M
4.27M
5.26M
5.65M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.43M
7.09M
6.59M
7.36M
Operating expense
12.84M
11.36M
11.85M
13.01M
Total operating expenses
14.20M
13.35M
13.36M
13.55M
Operating income
-8.91M
-7.37M
-8.02M
-11.07M
Other non operating income
-
-
-
-
EBT including unusual items
-7.86M
-8.15M
-7.03M
-9.48M
EBT excluding unusual items
-7.86M
-8.15M
-7.03M
-9.48M
Income tax expense
121.00K
26.00K
25.00K
55.00K
Effective tax rate
-1.54%
-0.32%
-0.36%
-0.58%
Other operating expenses
-
-
-
-
Net income
-7.98M
-8.18M
-7.05M
-9.54M
Net profit margin
-150.82%
-136.77%
-132.15%
-384.21%
Earnings per share
-
-
-
-0.26
Interest and investment income
122.00K
160.00K
377.00K
336.00K
Interest expense
-
-
-
-
Net interest expenses
122.00K
160.00K
377.00K
336.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.77M
-7.26M
-7.92M
-10.93M
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps